Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SODIUM IODIDE I 131

SODIUM IODIDE I-131

Standard Dose
0.8-100mCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 016517 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength CAPSULE;ORAL - 0.8-100mCi Sponsor CURIUM Submission history Latest submission status date: 2018-02-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 016517 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength CAPSULE;ORAL - 0.8-100mCi Sponsor CURIUM Submission history Latest submission status date: 2018-02-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SODIUM IODIDE I 131 (SODIUM IODIDE I-131) | Drug Monograph | MedicHelpline